IL145763A0 - Method for the treatment of incontinence - Google Patents

Method for the treatment of incontinence

Info

Publication number
IL145763A0
IL145763A0 IL14576300A IL14576300A IL145763A0 IL 145763 A0 IL145763 A0 IL 145763A0 IL 14576300 A IL14576300 A IL 14576300A IL 14576300 A IL14576300 A IL 14576300A IL 145763 A0 IL145763 A0 IL 145763A0
Authority
IL
Israel
Prior art keywords
incontinence
treatment
gamma
instant invention
aminobutyric acid
Prior art date
Application number
IL14576300A
Other languages
English (en)
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22434891&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL145763(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of IL145763A0 publication Critical patent/IL145763A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Seeds, Soups, And Other Foods (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
IL14576300A 1999-04-08 2000-01-27 Method for the treatment of incontinence IL145763A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12834799P 1999-04-08 1999-04-08
PCT/US2000/002141 WO2000061135A1 (en) 1999-04-08 2000-01-27 Method for the treatment of incontinence

Publications (1)

Publication Number Publication Date
IL145763A0 true IL145763A0 (en) 2002-07-25

Family

ID=22434891

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14576300A IL145763A0 (en) 1999-04-08 2000-01-27 Method for the treatment of incontinence

Country Status (13)

Country Link
EP (2) EP1977745B1 (hu)
JP (1) JP2002541198A (hu)
KR (1) KR20010103053A (hu)
AT (2) ATE413872T1 (hu)
AU (2) AU779262B2 (hu)
CA (1) CA2362026A1 (hu)
DE (2) DE60044160D1 (hu)
ES (2) ES2341059T3 (hu)
HU (1) HUP0200738A3 (hu)
IL (1) IL145763A0 (hu)
TR (1) TR200102837T2 (hu)
WO (1) WO2000061135A1 (hu)
ZA (1) ZA200107425B (hu)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003088335A (ja) * 2001-09-14 2003-03-25 Pharmafoods Kenkyusho:Kk 排尿機能改善用食品組成物及びそれを含有する飲食品
CA2451267A1 (en) * 2002-12-13 2004-06-13 Warner-Lambert Company Llc Pharmaceutical uses for alpha2delta ligands
JP2006511606A (ja) * 2002-12-13 2006-04-06 ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー 下部尿路症状を治療するα−２−δリガンド
EP1621193A3 (en) * 2002-12-20 2006-08-02 Dynogen Pharmaceuticals Inc. Treatment of non-painful bladder disorders using alpha2-delta-subunit calcium channel modulators
EP1480631B1 (en) * 2002-12-20 2007-08-01 Dynogen Pharmaceuticals Inc. Methods of treating non-painful bladder disorders using alpha2-delta- subunit calcium channel modulators
JP2006520799A (ja) * 2003-03-21 2006-09-14 ダイノジェン ファーマシューティカルズ， インコーポレイテッド 平滑筋調節因子およびα２δサブユニットカルシウムチャネル調節因子を用いた、下部尿路障害を処置するための方法
WO2005025562A1 (en) * 2003-09-11 2005-03-24 Xenoport, Inc. Treating and/or preventing urinary incontinence using prodrugs of gaba analogs
KR101096480B1 (ko) 2003-10-14 2011-12-20 제노포트 인코포레이티드 감마-아미노부티르산 유사체의 결정질 형태
EA017171B1 (ru) * 2006-12-22 2012-10-30 Рекордати Айерленд Лимитед КОМБИНИРОВАННАЯ ТЕРАПИЯ ЗАБОЛЕВАНИЙ НИЖНИХ МОЧЕВЫВОДЯЩИХ ПУТЕЙ С ИСПОЛЬЗОВАНИЕМ ЛИГАНДОВ αδ И НЕСТЕРОИДНЫХ ПРОТИВОВОСПАЛИТЕЛЬНЫХ ПРЕПАРАТОВ (НПВП)
EP2240158A2 (en) * 2007-12-28 2010-10-20 Intas Pharmaceuticals Limited Stabilized injectable formulation of pregabalin
TWI369202B (en) 2008-01-25 2012-08-01 Xenoport Inc Enantiomerically resolving acyloxyalkyl thiocarbonates used in synthesizing acyloxyalkyl carbamate prodrugs
WO2009094577A2 (en) 2008-01-25 2009-07-30 Xenoport, Inc. Mesophasic forms of (3s)-aminomethyl-5-methyl-hexanoic acid prodrugs and methods of use
EP2250148B1 (en) 2008-01-25 2016-08-17 XenoPort, Inc. Crystalline form of calcium-salts of (3s)-aminomethyl-5-methyl-hexanoic acids and methods of use
ES2423254B1 (es) * 2012-02-15 2014-03-26 Laboratec, S.L. Composición farmacéutica para el tratamiento de incontinencia urinaria y enuresis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU9137091A (en) * 1990-11-27 1992-06-25 Northwestern University Gaba and l-glutamic acid analogs for antiseizure treatment
RU2140901C1 (ru) * 1992-05-20 1999-11-10 Нортвестерн Юниверсити АНАЛОГИ γ-АМИНОМАСЛЯНОЙ КИСЛОТЫ, СПОСОБ ИХ ПОЛУЧЕНИЯ, СПОСОБ ЛЕЧЕНИЯ И ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ
IT1288123B1 (it) * 1996-09-04 1998-09-10 Nicox Sa Uso di nitroderivati per l'incontinenza urinaria
US20020045742A1 (en) * 1998-12-15 2002-04-18 Kenneth A. Jones Dna encoding a gaba b r2 polypeptide and uses thereof

Also Published As

Publication number Publication date
EP1171114B1 (en) 2008-11-12
HUP0200738A2 (hu) 2002-07-29
HUP0200738A3 (en) 2003-03-28
ATE463242T1 (de) 2010-04-15
DE60044160D1 (de) 2010-05-20
WO2000061135A1 (en) 2000-10-19
ATE413872T1 (de) 2008-11-15
ES2341059T3 (es) 2010-06-14
EP1977745B1 (en) 2010-04-07
JP2002541198A (ja) 2002-12-03
KR20010103053A (ko) 2001-11-17
EP1171114A1 (en) 2002-01-16
AU779262C (en) 2000-11-14
DE60040784D1 (de) 2008-12-24
ZA200107425B (en) 2003-02-26
CA2362026A1 (en) 2000-10-19
EP1977745A1 (en) 2008-10-08
TR200102837T2 (tr) 2002-03-21
AU2005200619A1 (en) 2005-03-10
ES2313880T3 (es) 2009-03-16
AU779262B2 (en) 2005-01-13
AU2741600A (en) 2000-11-14

Similar Documents

Publication Publication Date Title
WO2000002546A3 (en) Use of caba-analogues for treating insomnia
ZA200107425B (en) Method for the treatment of incontinence.
ZA976562B (en) Isobutylgaba and its derivatives for the treatment of pain.
EP1039887A4 (en) PROCESS FOR THE TREATMENT OF NEURO AND NEPHROTOXICITIES AND THERAPEUTIC TOXICITIES WITH AMINOTHIOL COMPOUNDS
IL208903A0 (en) Nociceptin analogs
WO2001078711A3 (en) Pde-v inhibitors for treatment of parkinson's disease
HK1043306A1 (en) 16-phenoxy-lipoxin analogs for medical use
EP1712236A3 (en) Tetracyclines for the treatment of acne
CA2157142A1 (en) Treatment of diseases caused by sebaceous gland disorders
IL162384A0 (en) Composition inhibiting matrix-metallproteinases for the treatment of neoplastic diseases
WO2002096362A3 (en) Method for treating fibrotic diseases or other indications vi
IL145122A0 (en) C16 unsaturated fp-selective prostaglandin analogs
AU2001249684A1 (en) Nasal administration of agents for the treatment of gastroparesis
BG105953A (en) Method for treating copd
UA66792C2 (uk) Спосіб отримання 2-арил-3-арил-5-галогенпіридинів, що використовуються як інгібітори сох-2 (варіанти)
IT1271141B (it) Procedimento per la potabilizzazione delle acque destinate al consumo umano
IL128028A0 (en) Treatment of psychotic disorders
HUT70757A (en) Pharmaceutical compositions for treating skin disorders
MY133014A (en) Method for treating copd
IL156140A0 (en) Use of substituted 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds for treating urinary incontinence
WO2002067851A3 (en) Method for treating fibrotic diseases or other indications iiic
AU8051891A (en) Means for treatment of diseases caused by microorganisms which is a solution of sodium thiosulphate and a weak acid and method of preparing it
PL345953A1 (en) The treatment of renal colic with gaba analogs
SI1304107T1 (en) Use of oxazolidinines derivatives for treating psoriasis

Legal Events

Date Code Title Description
FF Patent granted
MM9K Patent not in force due to non-payment of renewal fees